A new target for proteasome inhibitors: FoxM1

A novel mode of FoxM1 regulation: Positive auto-regulatory loop

(2011) Marianna Halasi et al.   CELL CYCLE

Novel anticancer compounds induce apoptosis in melanoma cells

(2010) Uppoor G. Bhat et al.   CELL CYCLE

p53 negatively regulates expression of FoxM1

(2010) Bulbul Pandit et al.   CELL CYCLE

Identification of Potential Therapeutic Targets in Malignant Mesothelioma Using Cell-Cycle Gene Expression Analysis

(2009) Solange Romagnoli et al.   AMERICAN JOURNAL OF PATHOLOGY

Critical Role and Regulation of Transcription Factor FoxM1 in Human Gastric Cancer Angiogenesis and Progression

(2009) Q. Li et al.   CANCER RESEARCH

FOXM1 Upregulation Is an Early Event in Human Squamous Cell Carcinoma and it Is Enhanced by Nicotine during Malignant Transformation

(2009) Emilios Gemenetzidis et al.   PLoS One

Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells

(2009) Uppoor G. Bhat et al.   PLoS One

FoxM1 Is a General Target for Proteasome Inhibitors

(2009) Uppoor G. Bhat et al.   PLoS One

Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer

(2008) Nuran Bektas et al.   BMC CANCER

Argyrin A Reveals a Critical Role for the Tumor Suppressor Protein p27kip1 in Mediating Antitumor Activities in Response to Proteasome Inhibition

(2008) Irina Nickeleit et al.   CANCER CELL

FoxM1-driven cell division is required for neuronal differentiation in early Xenopus embryos

(2008) H. Ueno et al.   DEVELOPMENT

FoxM1 inhibitors as potential anticancer drugs

(2008) Andrei L Gartel   EXPERT OPINION ON THERAPEUTIC TARGETS

Sustained NF-κB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1

(2008) Marianna Penzo et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis

(2008) DW Chan et al.   JOURNAL OF PATHOLOGY

Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression

(2008) J. M-M. Kwok et al.   MOLECULAR CANCER THERAPEUTICS

Is NF-κB a good target for cancer therapy? Hopes and pitfalls

(2008) Véronique Baud et al.   NATURE REVIEWS DRUG DISCOVERY